NOVANTA INC (NOVT) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 23, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for NOVANTA INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, NOVANTA INC's filing signal turned negative.
earningsVibe SuperAnalyst™ Verdict: TURNED NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-17.37%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Negative
CHATGPT
Turned Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does NOVANTA INC actually do?
Answer:
Novanta Inc. is a global supplier of core technology solutions for medical, life science, and advanced industrial original equipment manufacturers (OEMs), delivering extreme precision and performance. The company operates across two primary end markets: medical (53% of revenue in 2025) and advanced industrial (47% of revenue in 2025). Novanta's strategy focuses on profitable growth through its diversified business model, expanding its medical offerings via new products and acquisitions, and increasing penetration in high-growth advanced industrial applications like laser processing and robotics. It maintains a global manufacturing footprint with facilities in North America, Europe, and Asia, and sells primarily through a direct, technical sales force.
Question:
What are NOVANTA INC's revenue drivers?
Answer:
Revenue is driven by the sale of laser beam steering and scanning solutions, laser sources, robotic and precision motion products, and medical grade technologies including insufflators, endoscopic pumps, imaging, identification, and RFID solutions. Demand is influenced by capital spending in healthcare, growth in surgical procedures, and investments in manufacturing automation and advanced industrial processes.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required